A study confirms that the oral DPP-4 inhibitor linagliptin is a safe and effective means of lowering glucose levels for up to 102 weeks. The drug can lower glucose levels either on its own or in combination with other selected oral anti-diabetic medication. The study of the drug for people with type 2 diabetes was conducted in 32 countries including India. The study followed 2,121 individuals who had taken part in four previous 24-week randomised, double-blind, ...via Medindia Health News More READ
No comments:
Post a Comment